Forest Laboratories, Inc. (FRX) and Almirall, S.A. recently announced positive top-line data on their chronic obstructive pulmonary disease (COPD) fixed dose combination...(read more
Synergy Pharmaceuticals (SGYP) recently initiated a phase IIb study with plecanatide for the treatment of patients suffering from constipation-predominant irritable bowel...(read more
The following stocks have news that should keep them trading actively on Monday.
Forest Laboratories (NYSE:FRX)
The company lowered its fiscal year 2013 earnings guidance after...(read more